Single versus sequential high-dose chemotherapy (HOCT) in patients with relapsed or refractory germ-cell tumors (GCT).

被引：0
|
作者：
Lorch, A.
Rick, O.
Hartmann, J. T.
Kollmannsberger, C.
Metzner, B.
Schmidt-Wolf, I.
Berdel, W. E.
Schirren, R.
Beyer, J.
Bokemeyer, C.
机构：
[1] Univ Hosp, Marburg, Germany
[2] Klin Reinhardshoehe, Bad Wildungen, Germany
[3] Univ Hosp, Tubingen, Germany
[4] BC Canc Agcy, Vancouver, BC, Canada
[5] Staedt Kliniken, Oldenburg, Germany
[6] Univ Hosp Bonn, Bonn, Germany
[7] Univ Hosp, Munster, Germany
[8] Oberschwabenklin, Ravensburg, Germany
[9] Univ Hosp, Hamburg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：219S / 219S
页数：1
相关论文
共 50 条
  • [41] Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors
    Porfyriou, Eleni
    Letsa, Sylvia
    Kosmas, Christos
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (09): : 746 - 766
  • [42] Sequential high-dose chemotherapy with hematopoietic stem-cell support in poor risk, relapsed or refractory germ-cell tumor patient treatment: Lithuanian experience
    Korsakas, J.
    Andrekute-Aleksiejiene, K.
    Bukauskas, A.
    Brasiuniene, B.
    Trociukas, I.
    Jankevicius, F.
    Griskevicius, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 600 - 601
  • [43] Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancer
    Rick, O
    Bokemeyer, C
    Weinknecht, S
    Schirren, J
    Pottek, T
    Hartmann, IT
    Braun, T
    Rachud, B
    Weissbach, L
    Hartmann, M
    Siegert, W
    Beyer, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) : 3713 - 3719
  • [44] MULTI-CYCLE HIGH-DOSE CHEMOTHERAPY WITH TI-CE REGIMEN FOR PATIENTS WITH RELAPSED/REFRACTORY GERM CELL TUMORS - A SINGLE INSTITUTION EXPERIENCE
    De Giorgi, U.
    Rosti, G.
    Kopf, B.
    Ferrario, C.
    Papiani, G.
    De Vivo, R.
    Gentile, A. L.
    Fabbri, F.
    Bragagni, M.
    Amadori, D.
    ANNALS OF ONCOLOGY, 2012, 23 : 285 - 286
  • [45] Phase II-study of sequential High-Dose-Chemotherapy with Paclitaxel, Ifosfamide, Carboplatin, Etoposide (P-ICE) in patients with relapsed or refractory germ cell tumors (GCT)
    Cygon, F.
    Meinert, F.
    Hammad, K.
    Kegel, T.
    Steinbach, F.
    Seseke, F.
    Schmoll, H. -J.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 10 - 11
  • [46] Phase II-study of sequential high-dose-chemotherapy with paclitaxel, ifosfamide, carboplatin, etoposide(P-ICE) in patients with relapsed or refractory germ cell tumors (GCT).
    Kegel, Thomas
    Cygon, Franziska
    Meinert, Fabian Maximilian
    Hannmad, Khaled
    Steinbach, Frank
    Seseke, Florian
    Schmoll, Hans-Joachim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [47] Combination chemotherapy with gemcitabine, oxaliplatin and paclitaxel in patients with cisplatin-refractory or relapsed germ cell tumors (gct)
    Oechsle, K.
    Bokemeyer, C.
    Honecker, F.
    Mayer, F.
    Waller, C. F.
    Boehlke, I.
    Hartmann, J. T.
    Kollmannsberger, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Efficacy and safety of sequential high-dose chemotherapy (HDCT) for relapsed or refractory germ cell cancer in a unicentric standardized approach
    Niegisch, G.
    Henn, A.
    Zaum, M.
    Kobbe, G.
    Haas, R.
    Schirren, J.
    Albers, P.
    Lorch, A.
    Oncology Research and Treatment, 2015, 38 : 86 - 86
  • [49] Sequential high-dose chemotherapy (HDCT) for relapsed or refractory germ cell cancer (rGCC): Results of a unicentric standardized approach
    Niegisch, Guenter
    Henn, Alina
    Zaum, Martin
    Kobbe, Guido
    Haas, Rainer
    Schirren, Joachim
    Albers, Peter
    Lorch, Anja
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] High-dose chemotherapy followed by autologous peripheral blood progenitor cell rescue in patients with germ-cell tumors
    Nepomucká, J
    Boubliková, L
    Charvát, J
    Simková, V
    Kalanin, J
    Greplová, M
    Bartová, M
    Lukásová, M
    Abrahámová, J
    BONE MARROW TRANSPLANTATION, 1999, 23 : S192 - S192
12345